The latest research from Fore Pharma, Europe Migraine Market and Competitive Landscape – 2020, provides comprehensive insights into Migraine pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Migraine market size and drug sales. It also provides insights into Migraine epidemiology and late stage pipeline.
This research covers the following – Migraine treatment options, Migraine late stage clinical trials pipeline, Migraine prevalence by countries, Migraine market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).
Research Scope:
– Countries: Germany, France, Italy, Spain, UK, Europe
– Migraine pipeline: Find out drugs in clinical trials for Migraine by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Migraine epidemiology: Find out number of patients diagnosed (prevalence) with Migraine by countries
– Migraine drugs: Identify key drugs marketed and prescribed for Migraine by countries, including trade name, molecule name, and company
– Migraine drugs sales: Find out the sales value for Migraine drugs by countries
– Migraine market valuations: Find out the market size for Migraine drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Migraine drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Migraine drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Migraine market
– Develop in-depth knowledge of competition and markets
– Analyze Migraine drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Migraine market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Migraine Treatment Options
2. Migraine Pipeline Insights
2.1. Migraine Phase 3 Clinical Trials
2.2. Migraine Phase 2 Clinical Trials
2.3. Migraine Phase 1 Clinical Trials
3. Migraine Epidemiology Analysis by Countries
4. Germany Migraine Market Insights
4.1. Marketed Drugs for Migraine in Germany
4.2. Germany Migraine Market Size & Forecast
4.3. Germany Migraine Drugs Sales Forecast
4.4. Germany Migraine Market Share Analysis
5. France Migraine Market Insights
5.1. Marketed Drugs for Migraine in France
5.2. France Migraine Market Size & Forecast
5.3. France Migraine Product Sales Forecast
5.4. France Migraine Market Share Analysis
6. Italy Migraine Market Insights
6.1. Marketed Drugs for Migraine in Italy
6.2. Italy Migraine Market Size & Forecast
6.3. Italy Migraine Product Sales Forecast
6.4. Italy Migraine Market Share Analysis
7. Spain Migraine Market Insights
7.1. Marketed Drugs for Migraine in Spain
7.2. Spain Migraine Market Size & Forecast
7.3. Spain Migraine Product Sales Forecast
7.4. Spain Migraine Market Share Analysis
8. UK Migraine Market Insights
8.1. Marketed Drugs for Migraine in UK
8.2. UK Migraine Market Size & Forecast
8.3. UK Migraine Product Sales Forecast
8.4. UK Migraine Market Share Analysis
9. Europe Migraine Market Insights
9.1. Europe Migraine Market Size & Forecast
9.2. Europe Migraine Product Sales Forecast
9.3. Europe Migraine Market Share Analysis
10. Research Methodology
List of Tables
1: Migraine Phase 3 Clinical Trials, Global, 2020
2: Migraine Phase 2 Clinical Trials, Global, 2020
3: Migraine Phase 1 Clinical Trials, Global, 2020
4: Migraine Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Migraine in Germany, 2019
6: Germany Migraine Market Size & Forecast ($mn), 2016 – 2025
7: Germany Migraine Product Sales ($mn), 2016 – 2025
8: Germany Migraine Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Migraine in France, 2019
10: France Migraine Market Size & Forecast ($mn), 2016 – 2025
11: France Migraine Product Sales ($mn), 2016 – 2025
12: France Migraine Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Migraine in Italy, 2019
14: Italy Migraine Market Size & Forecast ($mn), 2016 – 2025
15: Italy Migraine Product Sales ($mn), 2016 – 2025
16: Italy Migraine Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Migraine in Spain, 2019
18: Spain Migraine Market Size & Forecast ($mn), 2016 – 2025
19: Spain Migraine Product Sales ($mn), 2016 – 2025
20: Spain Migraine Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Migraine in UK, 2019
22: UK Migraine Market Size & Forecast ($mn), 2016 – 2025
23: UK Migraine Product Sales ($mn), 2016 – 2025
24: UK Migraine Market Events and Trends, 2016 – 2025
25: Europe Migraine Market Size & Forecast ($mn), 2016 – 2025
26: Europe Migraine Product Sales ($mn), 2016 – 2025
List of Figures
1: Migraine Pipeline by Phase (%), Global, 2020
2: Migraine Prevalence by Countries, 2016 – 2025
3: Germany Migraine Market Size ($mn), 2016 – 2025
4: Germany Migraine Product Sales ($mn), 2016 – 2025
5: Germany Migraine Market Share by Drugs (%), 2019
6: Germany Migraine Market – Future Market Share (%), 2025
7: France Migraine Market Size ($mn), 2016 – 2025
8: France Migraine Product Sales ($mn), 2016 – 2025
9: France Migraine Market Share by Drugs (%), 2019
10: France Migraine Market – Future Market Share (%), 2025
11: Italy Migraine Market Size ($mn), 2016 – 2025
12: Italy Migraine Product Sales ($mn), 2016 – 2025
13: Italy Migraine Market Share by Drugs (%), 2019
14: Italy Migraine Market – Future Market Share (%), 2025
15: Spain Migraine Market Size ($mn), 2016 – 2025
16: Spain Migraine Product Sales ($mn), 2016 – 2025
17: Spain Migraine Market Share by Drugs (%), 2019
18: Spain Migraine Market – Future Market Share (%), 2025
19: UK Migraine Market Size ($mn), 2016 – 2025
20: UK Migraine Product Sales ($mn), 2016 – 2025
21: UK Migraine Market Share by Drugs (%), 2019
22: UK Migraine Market – Future Market Share (%), 2025
23: Europe Migraine Market Size ($mn), 2016 – 2025
24: Europe Migraine Product Sales ($mn), 2016 – 2025
25: Europe Migraine Market Share by Drugs (%), 2019
26: Europe Migraine Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.